- Home
- LXFR vs MGTX Comparison
LXFR vs MGTX Comparison
Compare LXFR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- MGTX
- Stock Information
- Founded
- LXFR 1898
- MGTX 2015
- Country
- LXFR United States
- MGTX United States
- Employees
- LXFR N/A
- MGTX N/A
- Industry
- LXFR Major Chemicals
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LXFR Industrials
- MGTX Health Care
- Exchange
- LXFR Nasdaq
- MGTX Nasdaq
- Market Cap
- LXFR 276.2M
- MGTX 302.6M
- IPO Year
- LXFR 2012
- MGTX N/A
- Fundamental
- Price
- LXFR $11.59
- MGTX $4.20
- Analyst Decision
- LXFR
- MGTX Strong Buy
- Analyst Count
- LXFR 0
- MGTX 2
- Target Price
- LXFR N/A
- MGTX $22.50
- AVG Volume (30 Days)
- LXFR 94.6K
- MGTX 156.8K
- Earning Date
- LXFR 10-23-2024
- MGTX 11-12-2024
- Dividend Yield
- LXFR 4.50%
- MGTX N/A
- EPS Growth
- LXFR N/A
- MGTX N/A
- EPS
- LXFR N/A
- MGTX N/A
- Revenue
- LXFR $382,400,000.00
- MGTX $8,122,000.00
- Revenue This Year
- LXFR N/A
- MGTX $133.83
- Revenue Next Year
- LXFR $7.60
- MGTX $655.34
- P/E Ratio
- LXFR N/A
- MGTX N/A
- Revenue Growth
- LXFR N/A
- MGTX 26.87
- 52 Week Low
- LXFR $7.55
- MGTX $3.49
- 52 Week High
- LXFR $13.52
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- LXFR 58.68
- MGTX 50.43
- Support Level
- LXFR $10.76
- MGTX $3.86
- Resistance Level
- LXFR $11.18
- MGTX $4.39
- Average True Range (ATR)
- LXFR 0.34
- MGTX 0.19
- MACD
- LXFR 0.11
- MGTX 0.04
- Stochastic Oscillator
- LXFR 89.74
- MGTX 64.81
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.